参考文献/References:
[1] Lee ST,Berlangieri SU,Poon AM,et al.Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules[J].Inter Med J,2007,37(11):753-759.
[2] 刘兰平,于金明,郭洪波,等.18F-FDGPET-CT确定非小细胞肺癌淋巴结放疗靶区的初步探讨[J].中华肿瘤杂志,2007,29(6):453-456.0
[3] Antoch G,Stattaus J,Nemat AT,et al.Non-small cell lung cancer:dual-modality PET/CT in preoperative staging[J].Radiology,2003,229(2):526-533.
[4] Kim YK,Lee KS,Kim BT,et al.Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country:diagnostic efficacy in 674 patients[J].Cancer,2007,109(6):1068-1077.
[5] Yi CA,Lee KS,Kim BT,et al.Efficacy of helical dynamic CT versus integrated PET/CT for detection of mediastinal nodal metastasis in non-small cell lung cancer[J].A JR Am J Roentgenol,2007,188(2):318-325.
[6] Lee BE,yon Haag D,Lown T,et al.Advances in positron emission tomography technology have increased the need for surgical staging in non-small cell lung cancer[J].J Thorac Cardiovasc Surg,2007,133(3):746-752.
[7] Borrego Doradol,Lopez Garcia C,Vazquez Albertion R,et al.Evaluation of efficacy and clinical impact of FDG-PET on patients with potentially respectable non-small cell lung cancer[J].Rev Esp Med Nucl,2007,26(6):335-344.
[8] Hellwig D,Graeter TP,Ukena D,et al.ISF-FDG PET for mediastinal staging of lung cancer:which SUV threshold makes sense?[J].J Nucl Med,2007,48(11):1761-1766.
[9] 刘方颖,张雪林,商健彪,等.18F-FDG PET显像在肺癌纵隔淋巴结转移诊断中的应用[J].第一军医大学学报,2004,24(10):1186-1187.
[10] Higashi K,Ito K,Hiramatsu Y,et al.18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer:,analysis of a muhicenter study[J].J Nucl Med,2005,46(2):267-275.
[11] Guhlmann A,Storck M,Kotzerke J,et al.Lymph node staging in non-small cell lung cancer,evaluation by[18F]FDG positron emission tomography (PET)[J].Thorax,1997,52(5):438-441.
[12] Uesaka D,Demura Y,Umeda Y,et al.Evaluation of FDG-PET imaging for the detection of gastrointestinal tract cancer in patients with suspected lung cancer[J].Nihon Kokyuki Gakkai Zasshi,2006,44(12):899-905.
[13] Cheran,S K,Hemdon JE 2nd,Patz EF Jr.Comparison of wholebody FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer[J].Lung Cancer,2004,44(3):317-325.
[14] Ishiguro T,Fu Y,Sadatou T,et al.Detection of unknown primary tumor in a patient with cerebellar metastasis using FDG PET-CT:ease report[J].No Shinkei Geka,2006,34(10):1027-1032.
[15] Sung YM.Lee KS.Kim BT,et al.Nonpalpable supraclavicular lymph nodes in lung cancer patients:preoperative characterization with 18F-FDG PET/CT[J].AIR Am J Roentgenol,2008,190(1):246-252.
[16] Schaffler GJ,Wolf G,Schoellnast H,et al.Non-small cell lung cancer:evaluation of pleural abnormalities on CT scans with 18F FDG PET[J].Radiology,2004,231(3):858-865.
[17] Yun M,Kim W,Alnafisi N,et al.18F-FDG PET in characterizing adrenal lesions detected on CT or MRI[J].J Nucl Med,2001,42(12):1795-1799.
[18] Eschmann SM,Friede G,Paulsen F,et al.Impact of staging with 18F-FDG-PET on outcome of patients with stage Ⅲ non-small cell lung cancer:PET identifies potential survivors[J].Eur J Nucl Med Mol hnaging,2007,34(1):54-59.
[19] Berghmans T,Dusart M,Paesmans M,et al.Primary tumor standardized uptake value (SUVmax) measnred on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC):a systematic review and meta-analysis (MA) by the european lung cancer working party for the IASLC lung cancer staging project[J].J Thorac Oncol,2008,3(1):6-12.
[20] Goodgame B,Pillot GA,Yang Z,et al.Prognostic value of preoperative positron emission tomography in reseeted stage I nonsmall cell lung cancer[J].J Thorac Oncol,2008,3(2):130-134.
[21] Raz DJ,Odisho AY,Franc BL,et al.Tumor fluoro-2-deoxy-Dglucose avidity on positron emission tomographie scan predicts mortality in patients with early-stage pure and mixed bronchioloal-veolar carcinoma[J].J Thorac Cardiovasc Surg,2006,132(5):1189-1195.
[22] Eschmann SM,Friedel G,Paulsen F,et al.Repeat 18F-FDG PET for monitoring neoadjuvant chemotherapy in patients with stage III non-small cell lung cancer[J].Lung Cancer,2007,55(2):165-171.
[23] Eschmann SM,Friedel G,Paulsen F,et al.18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer[J].Eur J Nucl Med Mol Imaging,2007,34(4):463-471.
[24] 刘素文,于金明,邢力刚.18F-FDG PET显像在非小细胞肺癌临床分期中的价值[J].中华肿瘤杂志,2004,26(10):626-629.
[25] van Baardwijk A,Bosmans G,Dekker A,et al.Time trends in the maximal uptake of FDG on PET scan during thoracic radiotherapy.A prospective study in locally advanced non-small cell lung cancer (NSCLC) patients[J].Radiother Oncol,2007,82(2):145-152.
[26] Hicks RJ,Kalff V,MacManus MP,et al.The utility of (18) F-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy:impact on management and prognostic stratification[J].J Nucl Med,2001,42(11):1605-1613.
[27] Higashi K,Ueda Y,Arisaka Y,et al.18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer[J].J Nucl Med,2002,43(1):39-45.
[28] 向作林,吴铮,陈刚,等.18F-脱氧葡萄糖hPET显像诊断非小细胞肺癌放化疗后复发病灶的价值[J].中国癌症杂志,2005,15(2):161-163.
[29] Brink I,Schumaeher T,Mix M,et al.Impact of[18F]FDG-PET on the primary staging of small-cell lung cancer[J].Eur J Nucl Med Mol Imaging,2004,31(12):1614-1620.
[30] Kut V,Spies W,Spies S,et al.Staging and monitoring of small cell lung cancer using[18F]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)[J].Am J Clin Oncol,2007,30(1):45-50.
[31] Mansueto M,Grimaldi A,Torbica A,et al.Cost-effectiveness analysis in the clinical management of patients with known or suspected lung cancer:[(18F)]fluorodeoxygtucose PET and CT comparison[J].Q J Nucl Med Mol Imaging,2007,51(3):224-234.
相似文献/References:
[1]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[2]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[3]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[4]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[5]李菲,黄俊星,张俊.18F-FDG PET/CT在食管癌中的临床应用[J].国际放射医学核医学杂志,2016,40(4):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
Li Fei,Huang Junxing,Zhang Jun.The clinical application of 18F-FDG PET/CT in esophageal cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
[6]许靖,李肖红,秦永德,等.帕金森病脑部葡萄糖代谢和脑多巴胺转运体PET显像特点的临床研究[J].国际放射医学核医学杂志,2016,40(5):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
Xu Jing,Li Xiaohong,Qin Yongde,et al.Clinical study of brain glucose metabolism and brain dopamine transporter PET imaging in patients with Parkinson’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
[7]霍小东,王慧星,阎卫亮,等.血管内皮抑制素对125I近距离照射裸鼠肺癌移植瘤的增敏效应研究[J].国际放射医学核医学杂志,2016,40(5):357.[doi:10.3760/cma.j.issn.1673-4114.2016.05.006]
Huo Xiaodong,Wang Huixing,Yan Weiliang,et al.Sensitization effect of endostatin for 125I brachytherapy on transplanted tumor in nude mice[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):357.[doi:10.3760/cma.j.issn.1673-4114.2016.05.006]
[8]曹登敏,林美福,陈文新,等.继发性骨淋巴瘤的18F-FDG PET/CT影像学表现[J].国际放射医学核医学杂志,2016,40(6):403.[doi:10.3760/cma.j.issn.1673-4114.2016.06.001]
Cao Dengmin,Lin Meifu,Chen Wenxin,et al.Analysis on 18F-FDG PET/CT imaging characteristics in secondary bone lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):403.[doi:10.3760/cma.j.issn.1673-4114.2016.06.001]
[9]李生栩,唐明灯,林端瑜,等.18F-FDG PET/CT在胸段食管鳞癌淋巴结转移中的诊断价值[J].国际放射医学核医学杂志,2016,40(6):408.[doi:10.3760/cma.j.issn.1673-4114.2016.06.002]
Li Shengxu,Tang Mingdeng,Lin Duanyu,et al.Value of 18F-FDG PET/CT in detecting metastatic lymph nodes of thoracic esophageal squamous cell carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):408.[doi:10.3760/cma.j.issn.1673-4114.2016.06.002]
[10]张莹莹,王振光,武凤玉,等.特发性肺间质纤维化HRCT病变区与非病变区18F-FDG PET/CT表现分析[J].国际放射医学核医学杂志,2016,40(6):414.[doi:10.3760/cma.j.issn.1673-4114.2016.06.003]
Zhang Yingying,Wang Zhenguang,Wu Fengyu,et al.18F-FDG PET/CT imaging analysis of regions with abnormal and normal pulmonary parenchyma on high resolution CT in idiopathic pulmonary fibrosis patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):414.[doi:10.3760/cma.j.issn.1673-4114.2016.06.003]
[11]付畅,史大鹏,徐俊玲,等.不同组织学类型肺癌患者大脑静息葡萄糖代谢改变研究[J].国际放射医学核医学杂志,2014,38(2):75.[doi:10.3760/cma.j.issn.1673-4114.2014.02.002]
Fu Chang,Shi Dapeng,Xu Junling,et al.The preliminary study of brain glucose metabolism changes in patients with lung cancer of different histological types[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):75.[doi:10.3760/cma.j.issn.1673-4114.2014.02.002]
[12]杨小丰,居热提·阿扎提,曹务成,等.肺癌患者体重、血糖浓度和病灶大小对18F-FDG PET/CT病灶SUV的影响[J].国际放射医学核医学杂志,2013,37(4):211.[doi:10.3760/cma.j.issn.1673-4114.2013.04.006]
YANG Xiao-feng,JURETI-Azhati,CAO Wu-cheng,et al.The effect of lung cancer patients’ weight, blood glucose concentration and lesion size of lung cancer on 18F-FDG PET/CT lesions SUV results[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):211.[doi:10.3760/cma.j.issn.1673-4114.2013.04.006]
[13]李乐保,彭翔,叶慧,等.18F-FDG PET-CT对周围型肺癌的诊断价值研究[J].国际放射医学核医学杂志,2010,34(4):209.[doi:10.3760/cma.j.issn.1673-4114.2010.04.005]
LI Le-bao,PENG Xiang,YE Hui,et al.The diagnostic value of PET-CT on peripheral lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(5):209.[doi:10.3760/cma.j.issn.1673-4114.2010.04.005]
[14]田亚东,袁卫红.影像学及肿瘤相关抗原在诊断肺癌中的应用[J].国际放射医学核医学杂志,2011,35(5):295.[doi:10.3760/cma.j.issn.1673-4114.2011.05.011]
TIAN Ya-dong,YUAN Wei-hong.Application of imaging and tumor-associated antigen in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(5):295.[doi:10.3760/cma.j.issn.1673-4114.2011.05.011]
[15]李亚军,白人驹,高硕,等.兔VX2肺肿瘤PET-CT与血管生成的相关性研究[J].国际放射医学核医学杂志,2010,34(3):139.
LI Ya-jun,BAI Ren-ju,GAO Shuo,et al.The correlation between PET-CT imaging and microvessed density in rabbit lung VX2 tumor model[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(5):139.
[16]任树华,华逢春,赵军.PET-CT乏氧显像及其在肺癌中的研究进展[J].国际放射医学核医学杂志,2008,32(5):286.
REN Shu-hua,HUA Feng-chun,ZHAO Jun.Advances of research on PET-CT hypoxia imaging in lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(5):286.
[17]谭延林,董楚宁,王云华.18F-FDG PET/CT在肺癌疗效评估中的价值[J].国际放射医学核医学杂志,2018,(4):357.[doi:10.3760/cma.j.issn.1673-4114.2018.04.013]
Tan Yanlin,Dong Chuning,Wang Yunhua.The value of 18F-FDG PET/CT on evaluating therapeutic effect in the treatment of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(5):357.[doi:10.3760/cma.j.issn.1673-4114.2018.04.013]
[18]柳卫,李天女,范磊,等.肺大细胞神经内分泌癌的18F-FDG PET/CT表现[J].国际放射医学核医学杂志,2018,(6):486.[doi:10.3760/cma.j.issn.1673-4114.2018.06.002]
Liu Wei,Li Tiannyu,Fan Lei,et al.18F-FDG PET/CT manifestations of pulmonary large cell neuroendocrine carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(5):486.[doi:10.3760/cma.j.issn.1673-4114.2018.06.002]